Canada markets open in 8 hours 22 minutes
  • S&P/TSX

    21,125.90
    -487.30 (-2.25%)
     
  • S&P 500

    4,594.62
    -106.84 (-2.27%)
     
  • DOW

    34,899.34
    -905.06 (-2.53%)
     
  • CAD/USD

    0.7840
    +0.0019 (+0.25%)
     
  • CRUDE OIL

    71.22
    +3.07 (+4.50%)
     
  • BTC-CAD

    73,248.98
    +3,564.70 (+5.12%)
     
  • CMC Crypto 200

    1,435.27
    -20.14 (-1.38%)
     
  • GOLD FUTURES

    1,797.50
    +9.40 (+0.53%)
     
  • RUSSELL 2000

    2,245.94
    -85.52 (-3.67%)
     
  • 10-Yr Bond

    1.4820
    0.0000 (0.00%)
     
  • NASDAQ futures

    16,209.25
    +158.25 (+0.99%)
     
  • VOLATILITY

    28.62
    +10.04 (+54.04%)
     
  • FTSE

    7,044.03
    -266.34 (-3.64%)
     
  • NIKKEI 225

    28,289.65
    -461.97 (-1.61%)
     
  • CAD/EUR

    0.6947
    +0.0042 (+0.61%)
     

BMY, HNST, HYZN, SAM INVESTOR ALERT BY CLAIMSFILER: Pending Lead Plaintiff Deadline in Class Action Lawsuits

·2 min read

NEW ORLEANS, Oct. 22, 2021 (GLOBE NEWSWIRE) -- ClaimsFiler, a FREE shareholder information service, reminds investors of pending deadlines in the following securities class action lawsuits:

The Boston Beer Company, Inc. (SAM)
Class Period: 4/22/2021 - 9/8/2021
Lead Plaintiff Motion Deadline: November 15, 2021
SECURITIES FRAUD
To learn more, visit https://claimsfiler.com/cases/nyse-sam/

The Honest Company, Inc. (HNST)
Class Period: purchase of shares issued either in or after the May 2021 Initial Public Offering
Lead Plaintiff Motion Deadline: November 15, 2021
MISLEADING PROSPECTUS
To learn more, visit https://claimsfiler.com/cases/nasdaq-hnst/

Hyzon Motors Inc. (HYZN, HYZNW) f/k/a Decarbonization Plus Acquisition Corporation (DCRB, DCRBU, DCRBW)
Class Period: 2/9/2021 - 9/27/2021
Lead Plaintiff Motion Deadline: November 29, 2021
SECURITIES FRAUD
To learn more, visit https://claimsfiler.com/cases/nasdaq-hyzn/

Bristol-Myers Squibb Company (BMY)
Class: Investors who received Contingent Value Rights (“CVRs”) (BMY.RT) in exchange for their shares of Celgene Corporation (CELG) pursuant to Bristol-Myers’ acquisition of Celgene on November 20, 2019
Lead Plaintiff Motion Deadline: December 6, 2021
MISLEADING PROSPECTUS
To learn more, visit https://claimsfiler.com/cases/nyse-bmy-3/

If you purchased shares of the above companies and would like to discuss your legal rights and your right to recover for your economic loss, you may, without obligation or cost to you, contact us toll-free (844) 367-9658 or visit the case links above.

If you wish to serve as a Lead Plaintiff in the class action, you must petition the Court on or before the Lead Plaintiff Motion deadline.

About ClaimsFiler

ClaimsFiler has a single mission: to serve as the information source to help retail investors recover their share of billions of dollars from securities class action settlements. At ClaimsFiler.com, investors can: (1) register for free to gain access to information and settlement websites for various securities class action cases so they can timely submit their own claims; (2) upload their portfolio transactional data to be notified about relevant securities cases in which they may have a financial interest; and (3) submit inquiries to the Kahn Swick & Foti, LLC law firm for free case evaluations.

To learn more about ClaimsFiler, visit www.claimsfiler.com


Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting